DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+23.38%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$3.48B
AUM Growth
+$624M
(+22%)
Cap. Flow
+$477M
Cap. Flow
% of AUM
13.71%
Top 10 Holdings %
Top 10 Hldgs %
38.49%
Holding
77
New
19
Increased
14
Reduced
16
Closed
11
Top Buys
| 1 |
Amgen
AMGN
|
$156M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$124M |
| 3 |
Dyne Therapeutics
DYN
|
$72.5M |
| 4 |
MindMed
MNMD
|
$62.7M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$58.8M |
Top Sells
| 1 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$52.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
$48.2M |
| 3 |
RAPT Therapeutics
RAPT
|
$44.6M |
| 4 |
Arcellx
ACLX
|
$40.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$34.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
RAPT Therapeutics
RAPT
$187M
| – | – |
-224,246
| Closed | -$44.6M |
|
|
ORTX
77
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| – | – |
-2,041,670
| Closed | -$33.6M |
|